Bank of New York Mellon Corp - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 90 filers reported holding UTAH MED PRODS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$2,700,292
-7.1%
31,399
+0.7%
0.00%0.0%
Q2 2023$2,907,002
-1.6%
31,191
+0.1%
0.00%0.0%
Q1 2023$2,953,040
-9.0%
31,160
-3.4%
0.00%0.0%
Q4 2022$3,243,853
+96.8%
32,268
+67.0%
0.00%
Q3 2022$1,648,000
+6.2%
19,324
+6.9%
0.00%
Q2 2022$1,552,000
-13.4%
18,074
-9.4%
0.00%
Q1 2022$1,793,000
-8.3%
19,948
+2.0%
0.00%
Q4 2021$1,956,000
-23.1%
19,559
-28.6%
0.00%
Q3 2021$2,543,000
+11.8%
27,399
+2.5%
0.00%
Q2 2021$2,274,000
+2.7%
26,733
+4.6%
0.00%
Q1 2021$2,214,000
+3.7%
25,565
+0.9%
0.00%
Q4 2020$2,135,000
+22.1%
25,338
+15.7%
0.00%
Q3 2020$1,749,000
-14.0%
21,907
-4.6%
0.00%
-100.0%
Q2 2020$2,034,000
-2.6%
22,957
+3.4%
0.00%0.0%
Q1 2020$2,088,000
-13.0%
22,194
-0.2%
0.00%0.0%
Q4 2019$2,399,000
+6.9%
22,236
-5.0%
0.00%0.0%
Q3 2019$2,244,000
+1.2%
23,410
+1.0%
0.00%0.0%
Q2 2019$2,218,000
+7.8%
23,175
-0.6%
0.00%0.0%
Q1 2019$2,057,000
+10.2%
23,306
+3.8%
0.00%0.0%
Q4 2018$1,866,000
-22.9%
22,451
-12.6%
0.00%0.0%
Q3 2018$2,419,000
-12.4%
25,675
+2.4%
0.00%0.0%
Q2 2018$2,761,000
+14.4%
25,070
+2.7%
0.00%0.0%
Q1 2018$2,413,000
+24.6%
24,410
+2.6%
0.00%0.0%
Q4 2017$1,937,000
-7.0%
23,787
-16.0%
0.00%0.0%
Q3 2017$2,083,000
+6.3%
28,308
+4.6%
0.00%0.0%
Q2 2017$1,960,000
+6.6%
27,072
-8.2%
0.00%0.0%
Q1 2017$1,838,000
-11.9%
29,492
+2.8%
0.00%0.0%
Q4 2016$2,087,000
+58.9%
28,677
+30.6%
0.00%
Q3 2016$1,313,000
-3.3%
21,960
+1.9%
0.00%
Q2 2016$1,358,000
+3.3%
21,549
+2.5%
0.00%
Q1 2016$1,315,000
+9.5%
21,026
+2.5%
0.00%
Q4 2015$1,201,000
-7.5%
20,513
-14.8%
0.00%
Q3 2015$1,298,000
-15.4%
24,082
-6.4%
0.00%
Q2 2015$1,534,000
+4.6%
25,721
+5.1%
0.00%
Q1 2015$1,466,000
+1.4%
24,478
+1.7%
0.00%
Q4 2014$1,446,000
+16.0%
24,065
-5.9%
0.00%
Q3 2014$1,247,000
-53.4%
25,574
-50.8%
0.00%
Q2 2014$2,676,000
+81.4%
52,024
+104.0%
0.00%
Q1 2014$1,475,000
+3.2%
25,508
+2.0%
0.00%
Q4 2013$1,429,000
-49.4%
25,002
-47.4%
0.00%
Q3 2013$2,824,000
+146.2%
47,492
+124.7%
0.00%
Q2 2013$1,147,00021,1350.00%
Other shareholders
UTAH MED PRODS INC shareholders Q1 2020
NameSharesValueWeighting ↓
HealthInvest Partners AB 42,000$3,899,0005.84%
Clean Yield Group 16,590$1,540,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 114,785$10,657,0000.39%
Ranger Investment Management 68,719$6,380,0000.34%
ISTHMUS PARTNERS, LLC 17,260$1,602,0000.29%
Cardinal Capital Management 10,093$937,0000.20%
GLOBEFLEX CAPITAL L P 6,336$588,0000.13%
Ancora Advisors LLC 31,362$2,912,0000.08%
Penobscot Investment Management Company, Inc. 4,000$371,0000.06%
SEIZERT CAPITAL PARTNERS, LLC 10,430$968,0000.04%
View complete list of UTAH MED PRODS INC shareholders